Spebrutinib besylate

Item number	Size	Delivery time	Price
TGM-T14357-25mg	25 mg	7 - 10 business days*	1,521.00€
TGM-T14357-50mg	50 mg	7 - 10 business days*	1,982.00€
TGM-T14357-100mg	100 mg	7 - 10 business days*	2,502.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Spebrutinib besylate (AVL-292 benzenesulfonate, CC-292 besylate) is a Btk kinase... more

Close menu

Product information "Spebrutinib besylate"

Description: Spebrutinib besylate (AVL-292 benzenesulfonate, CC-292 besylate) is a Btk kinase activity inhibitor with an IC50 of less than 0.5 nM and a Kinact/Ki of 7.69×10^4 M^-1s^-1. Target: BTK. Smiles: O=C(C=C)NC1=CC=CC(=C1)NC2=NC(=NC=C2F)NC3=CC=C(OCCOC)C=C3.O=S(=O)(O)C=1C=CC=CC1. References: Evans EK, et al. Inhibition of Btk with CC-292 provides early pharmacodynamic assessment of activity in mice and humans. J Pharmacol Exp Ther. 2013 Aug,346(2):219-28.

Keywords:	AVL-292 (benzenesulfonate), CC-292 (besylate)
Supplier:	TargetMol
Supplier-Nr:	T14357

Properties

Application:	Targets Bruton agammaglobulinemia tyrosine kinase [EC:2.7.10.2] (BTK)
MW:	581.62 D
Formula:	C28H28FN5O6S

Database Information

CAS :	1360053-81-1\| Matching products
KEGG ID :	K07370 \| Matching products

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Spebrutinib besylate"

Write a review